Investor Presentation • Nov 30, 2021
Investor Presentation
Open in ViewerOpens in native device viewer


This presentation does not constitute an offer to purchase the Company's securities or solicitation to receive such offers, and is designed solely to offer information as part of the Company's explanations on its 9M 2021 financial reports.
This presentation includes information regarding the Company's strategic plan for the years 2020-24. Accordingly, the presentation includes forward-looking information as defined in section 32A of the Securities Law 5728-1968.
The realization and/or non-realization of forward-looking information which is stated in the financial reports will be affected by risk factors that characterize the activities of the Company and group companies, as detailed in the Company's periodic reports, including changes in economic conditions, capital market in Israel and globally, the development of competition in the segments relevant to the group's activities, regulatory changes, changes in consumer preferences and consumption habits, a change in working assumptions or in the economic models and assumptions used by the consulting firm – that can not be estimated in advance and are not controlled by the Company. Hence, there is no certainty that the actual results and achievements of the Company in the future will be in accordance with these views and may differ, also substantially, from those presented in this presentation.
Furthermore, the presentation includes data and assessments based on external sources, the contents of which were not independently tested by the Company and therefore the Company is not responsible for their accuracy.
This presentation was drafted for the sake of convenience and needs to be reviewed along side with the Company's public reports, including 9M 2021 Financial Statements, which contain the complete information about the Company, before making any decision to invest in the Company's securities.
This presentation may include information that is presented differently from the way it was presented in the company's official reports, some information may be presented and/or categorized and/or edited and/or segmented differently from the company's official past reports.
For the avoidance of doubt, the Company does not undertake to update or change the information contained in this presentation.



Financial Results
Segment Breakdown
Investments
Appendix
Glossary



| Leading Israeli insurance, asset management & financial group |
TA35 index Since 2018 |
9.8 NISb Market cap(1) |
|---|---|---|
| Proven and recognized experience | 70+ Years of activity |
AA- / AA+ Holding / Insurance Rating |
| Trusted by millions of customers | >3m Clients c. half adult population |
Top Ranked in leaderboard for investments(2) |
| Strong capital position | 196% Solvency II Ratio(3) |
9.1 NISb Equity |
| High growth and compelling returns | 13% AUM CAGR 5-Year(4) |
15% ROE Average 5-Year(4) |
(1) As of November 24, 2021
(2) Based on yields in the general plans: #1 out of 5 in Policies (1991-2003), #1 out of 5 in Pension, & #3 out of 11 in Provident Funds
(3) As of June 30, 2021, unaudited, with transitional measures, proforma for 300 NISm dividend distribution from Phoenix Insurance to Phoenix Holdings
(4) From 30.9.2016 until 30.09.2021




Income from Broad Activities

Notes: Core fee businesses includes agencies, Excellence, and Gama. Investments include yields and variable management fees above 3% (previously reported within Insurance). See Appendix D for a detailed breakdown of 2019-20. For the convenience of the presentation, the statutory tax rate in insurance and the core fee business is used, while the difference between the actual tax and the statutory tax is recorded in Special Items respectively. See Glossary for definition of Special Items.



(1) Including LAT restatement for 2018-19; 2020 figure is before dividend distribution
(2) Including approximately 230 NISm of Mehadrin shares as a dividend in kind
(3) Mid-term Target based on 5-year plan and assuming 3% return on investments. ROE target range assumes 3% to 4.8% return on Nostro investments (4.8% based on average actual annual return during 1.10.15-30.9.20)
(4) Including 2020 share buy-back program 26 NISm plus cash dividend 380 NISm 2020 distributed during 2021 H1
(5) 74 NISm buyback during the reporting period; after report date the company announced 200 NISm dividend



Assessing multi-year plans and targets across group


(1) AUMs include Halman-Aldubi's 44 NISb corporate fund
(2) Before dividend distributions of 0.4 NISb in H1 2021 for 2020 income and 0.2 NISb announced in November for 2021
(3) Includes approximately 230 NISm of Mehadrin shares as a dividend in kind
(4) 2019 / 2020 / 9M2021 annual nominal nostro yields
Note: Mid-term Targets based on 5-year plan and assuming 3% return on investments. ROE target range assumes 3% to 4.8% return on Nostro investments (4.8% based on average actual annual return during 1.10.15-30.9.20). Actual performance will depend on financial markets, macroeconomic growth, industry trends, company performance and other variables

4





Priorities for next quarters



Segment Breakdown
Investments
Appendix
Glossary




| 12
(*) 13% CAGR not including Halman corporate funds
Premiums, Benefit Contributions, & Investment Contracts NISb



Comprehensive Income NISm



Comprehensive Income Before Tax NISm


| 15
(*) Investment income and variable management fees above 3% annual return (previously reported within insurance underwriting) and after offsetting the guaranteed yield to policyholders and interest expenses Note: For full breakdown please see Appendix B. See segment breakdowns for further details per segment.

Comprehensive Income NISm


Comprehensive Income Before Tax NISm







Financial Results
Investments
Appendix
Glossary









Comprehensive Income Before Tax
(*) The underwriting profit assume a real rate of return of 3%, investment income includes income from own (Nostro) investments above or below a 3% real return

Comprehensive Income Before Tax NISm



















-
Comprehensive Income Before Tax
Difference
5

5







Financial Results
Segment Breakdown
Appendix
Glossary




| 30
Q3/20 Q3/21 9M/20 9M/21


Pension Funds
Provident Funds
1 1
| 31


Financial Results
Segment Breakdown
Investments
Appendix
Glossary





(*) Investment income and variable Mang. fees above 3% annual return and after offsetting the guaranteed yield to policyholders and interest expenses.
| 34

| 35
(*) Investment income and variable Mang. fees above 3% annual return and after offsetting the guaranteed yield to policyholders (123M) and interest expenses.

(*) The company classified in relation to previous periods its variable management fees under 3% annual return to operation profit, investment income and variable management fees above 3% annual return and after offsetting the guaranteed yield to policyholders and interest expenses to capital market investments and actuarial research to special items


Financial Results
Segment Breakdown
Investments
Appendix
Glossary



| AM | Asset Management; i.e. Excellence Nessuah |
|---|---|
| AUM | Assets Under Management; the total market value of all the investments that are managed by the Group |
| Bps | Basis Points; 1 basis points is .01% |
| CGU | Cost Generating Unit |
| CI | Comprehensive Income |
| CLR | Combined Loss Ratio |
| CO | Corporate, Other and Consolidation |
| CPI | Consumer Price Index; measures the average change of prices in an agreed upon basket of consumer goods and services over time |
| CSM | Contractual Service Margin |
| D&O | Directors and Officers Liability Insurance |
| DAC | Deferred Acquisition Cost |
| ESOP | Employee Stock Ownership Plan; workplace benefit program, that provides the employees with ownership interest in the company. |
| ETF | Exchange Traded Fund; an open end, tradable basket of securities that tracks an underling index, sector, or security type |
| Fixed-Rate Gov Bonds | A government issued bond for which the interest income payment is agreed upon and does not change |
| FX | Foreign Exchange Currency |
| Gama | Financial services and credit company owned by the Phoenix Group |
| Halman corporate funds | Israeli Electric Company (IEC) |
| Illiquidity Premium | Or Liquidity Premium; premium demanded by investors when any given security cannot be easily converted into cash for its fair market value. |
| IMF | International Monetary Fund |
| Index Linked Gov Bonds | A government issued bond for which the interest income payment is related (or linked) to the CPI |
| LAT | Liability Adequacy Test |
| Liquidity Premium | See Illiquidity Premium |
| LOB | Line of Business |
| LTC | Long Term Care insurance; typically helps pay for costs associated with long term care |
| LTS | Long Term Services; including but not limited to Life, Provident and Pension funds |
| Marketable Securities | Liquid financial assets that can be quickly converted into cash; most are trading assets |


| MF | Management Fees; wages charged by a financial manager |
|---|---|
| Moody's | A credit risk rating agency |
| MSCI | Morgan Stanley Capital International Emerging Markets Index; measures the performance in equity markets, specifically in global emerging markets |
| Mutual Fund | Open end, non-tradable basket of securities that tracks the performance of an undelaying index, sector, or security type |
| Net Inflows | The net amount of new cash, excluding the impact of investment market value; calculated by subtracting withdrawals from new deposits |
| NIS | New Israeli Shekel |
| Non-Marketable Securities | Asset group that is considered to be difficult to buy or sell due to the fact they are not traded on any major exchange; could include government issued debt securities, limited partnerships, real estate investments and more |
| Nostro | The account in which a financial institution manages its own funds |
| OPEX | Operational Expenses |
| P&C | Property and Casualty insurance |
| PH | Phoenix holdings |
| PHI | Permanent Health Insurance |
| PI | Phoenix insurance |
| PLI | Professional Liability insurance |
| Reinsurance | A balancing risk strategy; one or more insurers that share the liability |
| Revenue | All encompassing streams of income; including, but not limited to: premium, management fees, benefit contributions |
| RFR | Risk Free Rates |
| ROE | Return On Equity; calculated by dividing net income over total equity |
| SME60 | "The Rest Index"; tracks the performance of the 60 largest market value companies that are excluded from the Tel Aviv Stock Exchange |
| Special Items | Changes in profit or loss that are not part of the usual business of the Company, including changes in actuarial research, actuarial model changes, other structural changes and strategic acquisition costs in AM segment |
| Tel Bond 20 | Index that tracks the performance of the 20 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 40 | Index that tracks the performance of the 40 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 60 | Index that tracks the performance of the 60 largest Index linked Corporate Bonds in terms of market value |
| TLV 125 | An index that tracks the performance of the 125 largest market value companies in the Tel-Aviv Stock Exchange |
| TLV 35 | An index that tracks the performance of the 35 largest market value companies in the TLV Stock Exchange |
| TLV 90 | An index that tracks the performance of the 90 largest market value companies in the TLV stock Exchange |
| TMTP | Transitional Measures on Technical Provisions |
| Workers' Compensation Insurance | Insurance coverage for employees' injuries or sickness |
| Yield Curve | A line that plots interest rates of bonds with equal credit risk with different maturity dates in the future |

Please contact us at [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.